VRTX Smart Money
Vertex Pharmaceuticals Incorporated
1W: +1.2%
1M: -1.3%
3M: +7.8%
YTD: +15.2%
1Y: +23.6%
3Y: +44.0%
5Y: +181.0%
$521.03
+3.54 (+0.68%)
Pre-Market: $528.45 (+7.42, +1.42%)
Weekly Expected Move ±4.1%
$480
$502
$524
$546
$567
Credit Risk of going bust: lower than 94% of companies Debt: 1.5% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.52 (down 99.9%), Vertex Pharmaceuticals Incorporated would be worth roughly what it owes.
Total debt $1.98B against a stock market value of $132.06B.
Distance to default 17.12 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $988.8M (short-term plus half of long-term), stock volatility 28.8%; Altman Z'' 8.18. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.52 (down 99.9%), Vertex Pharmaceuticals Incorporated would be worth roughly what it owes.
Total debt $1.98B against a stock market value of $132.06B.
Distance to default 17.12 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $988.8M (short-term plus half of long-term), stock volatility 28.8%; Altman Z'' 8.18. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 20261,873
Institutions Holding
+75 vs prior
90.0%
Ownership
+11.67%
198
New
703
Increased
729
Reduced
110
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-20 | Brennan Daniel J. | director | A-Grant/Award | 795 | $503.47 | $400K | Filing |
| 2026-09-08 | van Grunsven Jasper | officer: evp, cp and nppo | A-Grant/Award | 8,682 | $— | $0 | Filing |
| 2026-08-28 | Ambrose Kristen | officer: svp & chief accounting officer | A-Grant/Award | 5,000 | $— | $0 | Filing |
| 2026-08-27 | SACHS BRUCE I | director | G-Gift | 6,000 | $— | $0 | Filing |
| 2026-07-21 | Tatsis Ourania | officer: evp, chief reg. & quality off. | A-Grant/Award | 8,251 | $— | $0 | Filing |
| 2026-07-21 | Sachdev Amit | officer: evp chief patient & ext af off | A-Grant/Award | 8,251 | $— | $0 | Filing |
| 2026-07-02 | Tatsis Ourania | officer: evp, chief reg. & quality off. | S-Sale | 1,500 | $524.99 | $787K | Filing |
| 2026-07-02 | McKechnie Duncan | officer: evp, chief commercial officer | S-Sale | 1,541 | $519.00 | $800K | Filing |
| 2026-07-01 | Liu Joy | officer: evp and chief legal officer | S-Sale | 828 | $502.71 | $416K | Filing |
| 2026-06-26 | Bozic Carmen | officer: evp and cmo | S-Sale | 596 | $482.50 | $288K | Filing |
| 2026-06-18 | Bozic Carmen | officer: evp and cmo | S-Sale | 1,020 | $462.17 | $471K | Filing |
| 2026-06-15 | Bozic Carmen | officer: evp and cmo | S-Sale | 4,062 | $450.00 | $1.8M | Filing |
| 2026-06-05 | Bozic Carmen | officer: evp and cmo | S-Sale | 1,745 | $450.00 | $785K | Filing |
| 2026-06-01 | Liu Joy | officer: evp and chief legal officer | S-Sale | 828 | $439.91 | $364K | Filing |
| 2026-05-29 | Bozic Carmen | officer: evp and cmo | S-Sale | 1,974 | $450.00 | $888K | Filing |
| 2026-05-15 | Bozic Carmen | officer: evp and cmo | S-Sale | 1,354 | $453.45 | $614K | Filing |
| 2026-05-15 | Bunnage Mark E. | officer: evp, chief scientific officer | S-Sale | 33 | $453.45 | $15K | Filing |
| 2026-05-12 | Bozic Carmen | officer: evp and cmo | S-Sale | 6,988 | $450.00 | $3.1M | Filing |
| 2026-05-04 | Bhatia Sangeeta N. | director | S-Sale | 318 | $423.73 | $135K | Filing |
| 2026-05-01 | Schneider Jennifer | director | A-Grant/Award | 472 | $— | $0 | Filing |
| 2026-05-01 | Thornberry Nancy | director | A-Grant/Award | 472 | $— | $0 | Filing |
| 2026-05-01 | MCKENZIE DIANA | director | A-Grant/Award | 943 | $— | $0 | Filing |
| 2026-05-01 | Schneider Jennifer | director | D-Sale to Issuer | 796 | $— | $0 | Filing |
| 2026-05-01 | Liu Joy | officer: evp and chief legal officer | S-Sale | 1,104 | $425.02 | $469K | Filing |
| 2026-05-01 | Garber Alan M | director | A-Grant/Award | 472 | $— | $0 | Filing |
🏛️ Congressional Trades
25 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| 2026-09-04 | Ro Khanna | House | Buy | $1,001 - $15,000 | Filing |
| 2026-08-26 | David Taylor | House | Sell | $1,001 - $15,000 | Filing |
| 2026-08-25 | David J. Taylor | House | Sell | $1,001 - $15,000 | Filing |
| 2026-04-13 | Ro Khanna | House | Buy | $1,001 - $15,000 | Filing |
| 2026-03-27 | Alan Armstrong | Senate | Buy | $1,001 - $15,000 | Filing |
| 2026-01-29 | David Taylor | House | Sell | $1,001 - $15,000 | Filing |
| 2026-01-29 | David Taylor | House | Sell | $1,001 - $15,000 | Filing |
| 2026-01-28 | David J. Taylor | House | Sell | $1,001 - $15,000 | Filing |
| 2025-09-29 | Ro Khanna | House | Buy | $1,001 - $15,000 | Filing |
| 2025-09-05 | Ro Khanna | House | Sell | $1,001 - $15,000 | Filing |
| 2025-08-07 | David Taylor | House | Buy | $1,001 - $15,000 | Filing |
| 2025-08-06 | David J. Taylor | House | Buy | $1,001 - $15,000 | Filing |
| 2025-08-04 | Ro Khanna | House | Buy | $1,000 - $15,000 | Filing |
| 2025-06-11 | Lisa McClain | House | Sell | $1,001 - $15,000 | Filing |
| 2025-06-10 | Lisa C. McClain | House | Sell | $1,001 - $15,000 | Filing |
| 2025-06-10 | Lisa McClain | House | Sell | $1,001 - $15,000 | Filing |
| 2025-05-11 | Jefferson Shreve | House | Sell | $15,001 - $50,000 | Filing |
| 2025-03-19 | Byron Donalds | House | Sell | $1,001 - $15,000 | Filing |
| 2025-03-19 | Byron Donalds | House | Sell | $1,001 - $15,000 | Filing |
| 2025-03-12 | Jefferson Shreve | House | Buy | $15,001 - $50,000 | Filing |
| 2025-02-24 | Jefferson Shreve | House | Buy | $15,001 - $50,000 | Filing |
| 2025-02-23 | Jefferson Shreve | House | Buy | $15,001 - $50,000 | Filing |
| 2024-12-11 | Lisa McClain | House | Buy | $1,001 - $15,000 | Filing |
| 2024-11-15 | Ro Khanna | House | Buy | $1,001 - $15,000 | Filing |
| 2024-10-23 | Julia Letlow | House | Buy | $1,001 - $15,000 | Filing |
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| Capital World Investors | 26,115,014 | $13.0B | +746,890 | 2026-06-30 | Filing |
| BlackRock, Inc. | 24,109,373 | $12.0B | +139,856 | 2026-06-30 | Filing |
| Capital Research Global Investors | 19,490,637 | $9.7B | -1,635,327 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 16,580,713 | $8.2B | +67,903 | 2026-06-30 | Filing |
| STATE STREET CORP | 11,871,459 | $5.9B | +141,320 | 2026-06-30 | Filing |
| Invesco Ltd. | 8,043,052 | $4.0B | +2,711,498 | 2026-06-30 | Filing |
| JPMORGAN CHASE & CO | 6,517,600 | $3.3B | -515,556 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 6,017,848 | $3.0B | -121,773 | 2026-06-30 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4,878,987 | $2.4B | -266,622 | 2026-06-30 | Filing |
| Capital International Investors | 4,695,144 | $2.3B | -430,933 | 2026-06-30 | Filing |
| LOOMIS SAYLES & CO L P | 3,920,953 | $1.9B | -82,868 | 2026-06-30 | Filing |
| FRANKLIN RESOURCES INC | 3,347,253 | $1.7B | +2,796,121 | 2026-06-30 | Filing |
| WELLINGTON MANAGEMENT GROUP LLP | 3,247,658 | $1.6B | +35,069 | 2026-06-30 | Filing |
| MORGAN STANLEY | 3,242,139 | $1.6B | +53,258 | 2026-06-30 | Filing |
| UBS AM, a distinct business unit of UBS | 3,086,683 | $1.5B | +29,287 | 2026-06-30 | Filing |
| BANK OF AMERICA CORP /DE | 3,039,178 | $1.5B | +160,995 | 2026-06-30 | Filing |
| JENNISON ASSOCIATES LLC | 2,998,530 | $1.5B | +258,471 | 2026-06-30 | Filing |
| NORGES BANK | 2,971,681 | $1.5B | +2,971,681 | 2026-06-30 | Filing |
| ALLIANCEBERNSTEIN L.P. | 3,019,315 | $1.3B | -891,471 | 2026-06-30 | Filing |
| AMERIPRISE FINANCIAL INC | 2,604,822 | $1.3B | -28,659 | 2026-06-30 | Filing |